As a research center, The Institute conducts clinical trials of investigational new drugs and is a leader in outcome studies. Researchers at The Institute have also devised a unique computerized clinical alert system.
In 2002, The Institute opened the Olin Neuropsychiatry Research Center, a $25 million complex dedicated to research in schizophrenia and other neuropsychiatric disorders. Headed by Godfrey Pearlson, M.D., Olin Center researchers make use of sophisticated neuroimaging techniques and have attracted significant grant funding and competitive awards.
Most of the research at The Institute of Living takes place in the four research centers listed below. Detailed information is provided under each center:
The Anxiety Disorders Center specializes in the treatment and study of anxiety-related problems in adults, adolescents, and children. Treatment at the ADC emphasizes cognitive-behavioral therapy, an evidence-based approach to reducing fear and avoidance. Research studies investigate the outcome and process of cognitive-behavioral therapy, as well as the behavioral, cognitive, and neurobiological underpinnings of anxiety.
The Braceland Center conducts research and education to improve the health and well-being of older persons. There are a number of diverse research, evaluation, and education projects underway at the Braceland Center. Major areas of research address mental health issues and access, long term care and Alzheimer's disease, and health care quality and evaluation.
The Burlingame Center evaluates clinical care, manages the outcomes research program, conducts studies of new psychiatric therapies, and develops and implements computerized "decision support" tools. Through its Office of Professional and Community Education the Center also coordinates the Institute's professional education programs.
The Olin Neuropsychiatric Research Center conducts neuroscience research in severe psychiatric illnesses and to translate that research into new and effective treatments. Conditions studied include schizophrenia, manic-depressive illness, post-traumatic stress disorder, alcohol use disorder, teens with conduct problems, ADHD, PTSD, driving while intoxicated and Alzheimer’s disease.